Search results
Results from the WOW.Com Content Network
Pacemaker syndrome is a condition that represents the clinical consequences of suboptimal atrioventricular (AV) synchrony or AV dyssynchrony, regardless of the pacing mode, after pacemaker implantation. [1] [2] It is an iatrogenic disease—an adverse effect resulting from medical treatment—that is often underdiagnosed.
The Pathway was developed to aid members of a multi-disciplinary team in matters relating to continuing medical treatment, discontinuation of treatment and comfort measures during the last days and hours of a patient's life. The Liverpool Care Pathway was organised into sections ensuring that evaluation and care is continuous and consistent.
Failure of a pacemaker is defined by the requirement of repeat surgical pacemaker-related procedures after the initial implantation. Most implanted pacemakers are dual chambered and have two leads, causing the implantation time to take longer because of this more complicated pacemaker system.
Cardiac resynchronisation therapy (CRT or CRT-P) is the insertion of electrodes in the left and right ventricles of the heart, as well as on occasion the right atrium, to treat heart failure by coordinating the function of the left and right ventricles via a pacemaker, a small device inserted into the anterior chest wall.
The FDA approved the OPTIMIZER Smart System, which delivers cardiac contractility modulation therapy, as indicated to improve 6-minute hall walk distance, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline directed medical therapy, who are in normal sinus rhythm, are not indicated for cardiac resynchronization therapy, and ...
Pacemakers are also sometimes used to regulate the heartbeats in people with congenital heart disease, a group of conditions that affect about 1% of people born in the U.S., according to the ...
The Wanted vocalist, 36, revealed on Instagram on Saturday, Dec. 21, that he had a pacemaker fitted after announcing weeks earlier that recent tests had found "issues" with his heart.
The Mustard procedure was developed in 1963 by Dr. William Mustard at the Hospital for Sick Children.It is similar to the previous atrial baffle used with a Senning procedure, the primary difference being that the Mustard uses a graft made of Dacron or pericardium, while the Senning uses native heart tissue.